BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 17060574)

  • 1. Diagnostic challenges in facioscapulohumeral muscular dystrophy.
    Sacconi S; Salviati L; Bourget I; Figarella D; Péréon Y; Lemmers R; van der Maarel S; Desnuelle C
    Neurology; 2006 Oct; 67(8):1464-6. PubMed ID: 17060574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FSHD-like patients without 4q35 deletion.
    Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
    J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing the 4qA and 4qB variants is essential for the diagnosis of facioscapulohumeral muscular dystrophy in the Chinese population.
    Wang ZQ; Wang N; van der Maarel S; Murong SX; Wu ZY
    Eur J Hum Genet; 2011 Jan; 19(1):64-9. PubMed ID: 20736973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere.
    Lemmers RJ; de Kievit P; Sandkuijl L; Padberg GW; van Ommen GJ; Frants RR; van der Maarel SM
    Nat Genet; 2002 Oct; 32(2):235-6. PubMed ID: 12355084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
    Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
    Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
    Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
    J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rimmed vacuoles in facioscapulohumeral muscular dystrophy: a unique ultrastructural feature.
    Neudecker S; Krasnianski M; Bahn E; Zierz S
    Acta Neuropathol; 2004 Sep; 108(3):257-9. PubMed ID: 15221332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy.
    Goto K; Nishino I; Hayashi YK
    Neuromuscul Disord; 2006 Apr; 16(4):256-61. PubMed ID: 16545566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facioscapulohumeral dystrophy presenting as infantile facial diplegia and late-onset limb-girdle myopathy in members of the same family.
    Felice KJ; Jones JM; Conway SR
    Muscle Nerve; 2005 Sep; 32(3):368-72. PubMed ID: 15880682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD).
    van der Maarel SM; Deidda G; Lemmers RJ; Bakker E; van der Wielen MJ; Sandkuijl L; Hewitt JE; Padberg GW; Frants RR
    J Med Genet; 1999 Nov; 36(11):823-8. PubMed ID: 10544225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent somatic mosaicism for D4Z4 contractions in a family with facioscapulohumeral muscular dystrophy.
    Buzhov BT; Lemmers RJ; Tournev I; van der Wielen MJ; Ishpekova B; Petkov R; Petrova J; Frants RR; Padberg GW; van der Maarel SM
    Neuromuscul Disord; 2005 Jul; 15(7):471-5. PubMed ID: 15935668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
    Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
    Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical facet of Möbius syndrome: association with facioscapulohumeral muscular dystrophy.
    Kolski HK; Leonard NJ; Lemmers RJ; Bamforth JS
    Muscle Nerve; 2008 Apr; 37(4):526-9. PubMed ID: 18059038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
    Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
    J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene diagnosis of facioscapulohumeral muscular dystrophy].
    Zhang JL; Shen DG; Zhou PK; Liu JW; Jia N; Liu H; Wang HB; Yang SX; Frants RR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):232-4. PubMed ID: 12778451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD.
    de Greef JC; Wohlgemuth M; Chan OA; Hansson KB; Smeets D; Frants RR; Weemaes CM; Padberg GW; van der Maarel SM
    Neurology; 2007 Sep; 69(10):1018-26. PubMed ID: 17785671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
    Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD).
    Dai Y; Li P; Wang Z; Liang F; Yang F; Fang L; Huang Y; Huang S; Zhou J; Wang D; Cui L; Wang K
    J Med Genet; 2020 Feb; 57(2):109-120. PubMed ID: 31506324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.